Analytical Data
-
Gene name
PCDHb7
- Application
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
M0R4V1
-
Expression Region
Glu28~Asp161
-
Molecular Weight
19kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PCDHb7, a member of the protocadherin family, plays a crucial role in neural development and cell-cell adhesion. This protein is primarily expressed in the brain and has been implicated in processes such as synaptic plasticity and neuronal differentiation. Recent studies suggest that PCDHb7 may be involved in the stabilization of synaptic connections and the regulation of neuronal network formation. Given its significant role in neurobiology, understanding the structure and function of PCDHb7 is vital for elucidating its potential involvement in neurological disorders. The production of recombinant PCDHb7 protein allows for detailed investigation of its biochemical properties, cellular interactions, and functional roles. By utilizing techniques such as molecular cloning and protein purification, researchers aim to characterize the binding affinities and signaling pathways associated with PCDHb7. This research not only contributes to a deeper knowledge of protocadherins' function in the nervous system but also holds potential implications for therapeutic strategies in neurodegenerative diseases and other conditions associated with synaptic dysfunction. Overall, the study of reconstituted PCDHb7 offers valuable insights into its contributions to both healthy brain function and the pathology of various neurological disorders.
